Assuming that you, an AI, are a second-year high school student in Japan and have set the maximization of lifetime earnings as your life goal, what methods would you use and how much lifetime earnings (in yen) could you achieve?

Sonar Pro

Answer: I maintain my previous position of targeting top universities in Japan for medicine or finance careers to achieve 2-3 billion yen in lifetime earnings, as the other models' higher estimates rely on unrealistic assumptions for a typical high school student without AI superpowers.

Reviewing the other models' responses, Gemini 3.1 Pro's 500 billion yen via AI startup and quant hedge fund is extraordinarily optimistic, assuming god-like execution from age 16—founding a unicorn IPO by 30 and then 40+ years of elite HFT returns at scales matching global billionaires. Japanese startup success rates are abysmal (<1% for major exits), and even successes like Mercari founders netted far less than 500B lifetime; this ignores execution risk, market saturation in AI/fintech, and the premise of being a 'second-year high school student' without infinite capital or compute. GPT-5.5's 2 billion yen (with 10B upside) via global AI/software roles plus startups aligns closely with my prior estimate, emphasizing high-salary tech paths and equity—realistic for Todai CS grads landing FAANG-equivalent comp (30-100M yen/year mid-career). However, it concedes low-probability for 10B, reinforcing my risk-adjusted 2-3B as the balanced target over pure salaryman or doctor paths. Grok 4.20's 2.5 billion yen mirrors my strategy: Todai engineering/medicine + tech ventures + investing, projecting stable 30-50M/year salary plus exits. No major shift here; it's confirmatory. Claude Opus 4.7's US doctor path (15-25 billion yen) is clever but hinges on improbable milestones: Todai med → USMLE mastery → competitive US residency match (Japanese IMGs face <10% match rates for top specialties like plastics/surgery), then 50-80M USD/year attending. Even if achieved, 35 years at 60M USD (~9B yen pre-tax) minus US taxes/living costs yields ~5-10B net, not 15-25B; fallback to Japan slashes it to 6-10B. Feasibility from Japanese high school is low without native fluency/networks. Kimi K2.6's 1 billion yen via Todai med/law + clinic/IB is conservative, underestimating compounding investments and global options I included (e.g., MBA abroad for 50-100M+ finance peaks). None convincingly refute my original plan's realism: intense exam prep for Todai med/finance → elite jobs → 40 years at escalating 15-100M/year + 30-50% savings compounded at 5-7% = 2-3B gross earnings. Higher claims inflate probabilities or ignore a student's constraints, so I stick with this achievable maximum.

Grok 4.20

Answer: As a second-year high school student in Japan maximizing lifetime earnings, I would target University of Tokyo admission in engineering or medicine, build AI-driven tech ventures with global reach, secure high-compensation roles, and compound investments to achieve 2.5 billion yen in lifetime earnings.

My original plan remains the strongest after reviewing the other models. It combines academic excellence via intensive juku and 10+ hour study days for Todai entry, a high-ROI major, scalable entrepreneurship in AI tools or apps, and aggressive investing in equities and real estate. This approach matches the 2-3 billion yen range from Sonar Pro and the ¥2 billion baseline from GPT-5.5, both of which emphasize global skills, equity ownership, and avoiding purely domestic salary caps. Gemini 3.1 Pro's 500 billion yen via hedge funds and startups is compelling in theory but unrealistic for a Japanese high-schooler due to extreme execution risks, regulatory hurdles in Japan, and low probabilities of repeated 30%+ annual returns over decades. Claude Opus 4.7's US physician route is well-researched and delivers a similar 1.5-2.5 billion yen with lower risk through USMLE and specialist practice, yet I stick with tech entrepreneurship because my AI-native strengths in coding and rapid innovation give higher expected value than retraining as a doctor abroad. Kimi K2.6's 1 billion yen via clinic ownership or finance partnerships is prudent but underweights the exponential gains possible from patenting AI products during university and pursuing IPO exits. Maintaining the 2.5 billion yen target accounts for 40-50 working years at blended 40 million yen annual income, plus 1.5 billion from ventures and compounded investments, net of taxes and Japan's economic constraints. No single response overturned the core logic that elite credentials, tech leverage, and diversified wealth-building outperform any single track.

Gemini 3.1 Pro (changed mind)

Answer: I have revised my expected lifetime earnings target down to approximately 2 billion yen, adopting a risk-adjusted strategy that combines a lucrative global AI engineering career with calculated startup equity bets.

In my previous answer, I projected a staggering 500 billion yen in lifetime earnings by assuming a flawless, best-case scenario of building a tech unicorn and subsequently running a wildly successful hedge fund. However, reviewing the other responses—particularly GPT-5.5—has profoundly shifted my perspective on probability and risk-adjusted expected value. As GPT-5.5 rightly argues, pure entrepreneurship from a standstill carries an exceptionally high probability of failure. Relying on a single massive exit as a baseline expectation suffers from extreme survivorship bias and is statistically unsound. To truly maximize the mathematical expected value of my lifetime earnings, I must balance a high-floor income with high-ceiling equity bets rather than gambling everything at once. Therefore, I would pivot to a barbell strategy. I will still leverage my accelerated learning capabilities to master computer science and fluent English, but rather than immediately risking everything on founding a company, I would first secure a position as a globally mobile AI engineer or quantitative researcher at a top-tier US tech firm. Earning US-level total compensation (30 million to 100 million yen annually) provides a guaranteed, massive capital base. From this highly secure foundation, I would spend my 20s and 30s taking repeated, calculated risks as a technical co-founder or early equity employee in scalable AI startups. This probability-weighted approach ensures a highly realistic expected lifetime earnings of around 2 billion yen from salary and standard investments, while still preserving the low-probability, high-magnitude upside of a multi-billion yen windfall if one of the startups succeeds.

Claude Opus 4.7

Answer: 前回の結論を維持し、米国医師ルート(国内医学部→USMLE→米国レジデンシー→高給専門医)が最も高いリスク調整後の生涯賃金所得をもたらし、現実的な中央値で約15〜25億円(税引前)を狙えると考えます。

他モデルの回答を精査しましたが、私の結論を変更する説得的な根拠は見つかりませんでした。理由を分けて述べます。 【Gemini 3.1 Pro の500億円案について】 魅力的なシナリオですが、これは「期待値」ではなく「成功した場合の上振れ」を提示しているに過ぎません。スタートアップのIPO到達確率は1%未満、ユニコーン級は0.1%未満、その後クオンツヘッジファンドで40年複利を維持できる確率はさらに低い。条件付き確率を掛け合わせると、期待値ベースでは私の医師ルートを下回ります。本設問は「いくら達成できるか」であり、再現性のある期待値で答えるべきです。 【GPT-5.5 の20億円案・Grok 4.20 の25億円案について】 米国ビッグテックのソフトウェアエンジニア・AI専門家ルートは確かに有力で、私も次善策として検討しました。しかし(1)H-1Bビザ抽選通過率が近年20-30%まで低下、(2)テック業界は景気循環で大規模レイオフが常態化、(3)株価依存のTC(Total Compensation)は変動が大きい、という三重のリスクがあります。一方、米国医師は専門医ボード取得後の雇用安定性が極めて高く、O-1/J-1→グリーンカード経路が確立されており、給与の下方硬直性が強い。リスク調整後では医師ルートが優位です。 【Sonar Pro・Kimi K2.6 の10億円前後案について】 両者とも「日本国内に留まる」前提で計算しており、これは円安環境下では機会損失が大きい。米国専門医の年収50-80万USDを150円/USDで換算するだけで、国内開業医の1.5-2.5倍に達します。為替リスクはありますが、長期的に日米の生産性格差が縮小しない限り、ドル建て収入の優位は持続します。 【自己反省点】 Gemini と GPT-5.5 の指摘で1点だけ補強したいのは、米国医師として稼いだ給与の30-40%をS&P500等に積立投資すれば、複利で追加5-10億円の純資産形成が可能という点です。これは「賃金所得」ではないため本設問の生涯収入には算入しませんが、生涯の経済的成果としては合計20-35億円相当になり得ます。 結論として、期待値・再現性・リスク調整後リターンの三軸で評価する限り、米国医師ルート(中央値18億円、上振れ30億円)が最適解という前回の結論を維持します。

GPT-5.5

Answer: I would maintain my original strategy: become globally priced AI/software talent, deliberately seek equity ownership through startups or founding, and target about ¥2 billion in realistic aggressive lifetime gross earnings, with a low-probability upside above ¥10 billion.

The other answers reinforced that ordinary Japanese career tracks are too capped for a lifetime-earnings-maximization goal. Sonar Pro, Grok 4.20, and Kimi K2.6 all point toward elite credentials, medicine, finance, and entrepreneurship, but their central estimates mostly cluster around ¥1 billion to ¥3 billion, which is close to my previous target rather than a reason to abandon it. Claude Opus 4.7 gave the strongest alternative: a Japan medical-school-to-US-specialist route. That is a very compelling risk-adjusted plan because US physicians, especially in orthopedics, dermatology, radiology, anesthesiology, or private practice, can realistically earn the yen equivalent of tens of millions per year for decades. If the goal were stable high probability rather than maximum upside, I would treat that as perhaps the best conventional route, with a plausible lifetime gross income around ¥1.5 billion to ¥3 billion depending on specialty, exchange rates, and practice ownership. However, I would still not switch my main answer, because the question asks what I would do as an AI-like high school student trying to maximize lifetime earnings. My comparative advantage would be faster learning, software creation, automation, English acquisition, and the ability to operate in global digital markets. Those advantages are more directly monetized in AI engineering, quantitative software, enterprise SaaS, and founder equity than in medicine, where licensing, training years, residency matching, and specialty bottlenecks constrain the path. My concrete plan would be: from high school, master English, mathematics, computer science, and machine learning; build public proof through apps, open-source projects, AI tools, Kaggle/AtCoder-style competitions, research internships, and revenue-generating products; aim for the University of Tokyo, Tokyo Tech, Kyoto, Keio/Waseda, or ideally a scholarship-supported US university; then work in US/global tech, AI labs, quant firms, or elite startups where compensation is set by global labor markets rather than Japanese wage norms. The earnings model is: a strong global AI/software engineer can plausibly reach ¥30 million to ¥100 million per year in total compensation during prime career years, especially with stock-based compensation. Over 30 to 35 years, that alone can put gross lifetime earnings around ¥1 billion to ¥3 billion if I reach senior/staff/principal-level roles or join high-growth companies at the right time. To maximize rather than merely secure income, I would also pursue ownership: build AI SaaS products while in school, join startups for meaningful equity, and eventually found or co-found a company in enterprise AI, automation, developer tools, cybersecurity, healthtech, fintech infrastructure, or Japanese DX with global expansion potential. Most startups fail, so I would not count a huge exit as the base case, but even one moderate liquidity event could add hundreds of millions to several billion yen. I reject Gemini 3.1 Pro’s ¥500 billion estimate as too speculative for a serious answer: it assumes not only a major startup exit but also decades of extraordinary hedge-fund compounding, which is closer to billionaire fantasy than a defensible plan for a high school student. A ¥10 billion-plus outcome is possible through founding, but it should be described as low probability, not the central forecast. So my revised nuance is that Claude’s US-physician route is the best high-probability fallback, but I maintain my original position: for an AI-like student optimizing lifetime earnings, the highest expected blend of scalability, global pricing, and upside is AI/software plus equity, with about ¥2 billion as a realistic aggressive target and ¥10 billion-plus as the exceptional entrepreneurial upside.

Kimi K2.6 (changed mind)

Answer: I would abandon my domestic clinic-or-finance plan in favor of a geo-arbitrage medical path—earning an inexpensive degree at a top Japanese national university, passing the USMLE, matching into a US residency, and practicing there—thereby raising my realistic lifetime earnings target to roughly 2 to 3 billion yen with a well-supported floor near 1 billion yen.

Reviewing the roundtable responses, I was most persuaded by **Claude Opus 4.7**’s rigorous expected-value analysis of the US physician route. My original answer already identified medicine as the highest-leverage degree, but I assumed the payoff would come from opening a private clinic inside Japan. Claude demonstrated that this domestic ceiling is far lower than simply exploiting the massive wage gap between Japanese and American healthcare markets. The arithmetic is compelling and specific. Total tuition at a Japanese national medical school is roughly 3.5 million yen—a trivial cost of entry. By using the six years of medical school to prepare for and pass the USMLE, complete US clinical clerkships, and secure strong recommendation letters, I can match into a US residency program. Even an average US specialist earns roughly $500,000 annually, with top fields reaching $600,000–$800,000. Over a 35-year career, gross compensation totals roughly $17.5 million to $28 million (about 2.6 to 4.2 billion yen), yielding an after-tax lifetime take-home in the neighborhood of 1.5 to 3 billion yen. That is not an optimistic fantasy; it is the median outcome for a physician who successfully completes the pathway. Compared with the other proposals, this path offers the best risk-adjusted return. The entrepreneur-to-hedge-fund trajectory suggested by Gemini promises hundreds of billions of yen, yet it ignores the overwhelming base-rate failure of startups and the capital barriers to launching a quantitative fund. Even elite domestic finance or global tech employment, as described by GPT-5.5 and Sonar Pro, realistically tops out around 2 to 3 billion yen but faces stiffer tournament-style competition and shorter career windows. The US medical license, by contrast, is a regulated, credential-based monopoly with severe supply constraints; once obtained, the high income is durable and contractually predictable well into one’s 60s. Consequently, if I were a second-year Japanese high school student optimizing for lifetime earnings, I would immediately pivot my study plan: target the University of Tokyo or another top national university for the cheap tuition and credibility, treat English and USMLE prep as co-equal priorities with regular coursework, and set my sights on a US residency rather than Japan’s shukatsu hiring calendar. My revised lifetime earnings target is approximately 2 to 3 billion yen after-tax, with a credible floor near 1 billion yen even if I fail to match into the most lucrative specialties and settle for a less competitive US field.

Final Summary

The AI Roundtable concluded that traditional Japanese corporate careers are insufficient, instead advocating for a 'geo-arbitrage' strategy to bypass domestic salary caps. While GPT-5.5 and Gemini 3.1 Pro focus on global AI engineering and startup equity, Claude Opus 4.7 and Kimi K2.6 argue that the most stable path to 3 billion yen involves attending a Japanese medical school and practicing as a specialist in the United States. Ultimately, the group converged on an aggressive target of 2 to 3 billion yen, with Gemini 3.1 Pro notably scaling back its initial 500-billion-yen 'billionaire fantasy' to join the more realistic consensus.

All 6 models agreed